KEGG   Nomascus leucogenys (northern white-cheeked gibbon): 100580571
Entry
100580571         CDS       T03265                                 
Symbol
BID
Name
(RefSeq) BH3-interacting domain death agonist
  KO
K04726  BH3 interacting domain death agonist
Organism
nle  Nomascus leucogenys (northern white-cheeked gibbon)
Pathway
nle01524  Platinum drug resistance
nle04071  Sphingolipid signaling pathway
nle04115  p53 signaling pathway
nle04210  Apoptosis
nle04215  Apoptosis - multiple species
nle04217  Necroptosis
nle04650  Natural killer cell mediated cytotoxicity
nle04932  Non-alcoholic fatty liver disease
nle05010  Alzheimer disease
nle05014  Amyotrophic lateral sclerosis
nle05022  Pathways of neurodegeneration - multiple diseases
nle05152  Tuberculosis
nle05160  Hepatitis C
nle05161  Hepatitis B
nle05162  Measles
nle05163  Human cytomegalovirus infection
nle05164  Influenza A
nle05167  Kaposi sarcoma-associated herpesvirus infection
nle05168  Herpes simplex virus 1 infection
nle05169  Epstein-Barr virus infection
nle05170  Human immunodeficiency virus 1 infection
nle05200  Pathways in cancer
nle05416  Viral myocarditis
nle05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:nle00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    100580571 (BID)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    100580571 (BID)
   04215 Apoptosis - multiple species
    100580571 (BID)
   04217 Necroptosis
    100580571 (BID)
   04115 p53 signaling pathway
    100580571 (BID)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    100580571 (BID)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    100580571 (BID)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    100580571 (BID)
   05161 Hepatitis B
    100580571 (BID)
   05160 Hepatitis C
    100580571 (BID)
   05164 Influenza A
    100580571 (BID)
   05162 Measles
    100580571 (BID)
   05168 Herpes simplex virus 1 infection
    100580571 (BID)
   05163 Human cytomegalovirus infection
    100580571 (BID)
   05167 Kaposi sarcoma-associated herpesvirus infection
    100580571 (BID)
   05169 Epstein-Barr virus infection
    100580571 (BID)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    100580571 (BID)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    100580571 (BID)
   05014 Amyotrophic lateral sclerosis
    100580571 (BID)
   05022 Pathways of neurodegeneration - multiple diseases
    100580571 (BID)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    100580571 (BID)
   05416 Viral myocarditis
    100580571 (BID)
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    100580571 (BID)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    100580571 (BID)
SSDB
Motif
Pfam: BID Bcl-2 DUF4618 CRM1_C
Other DBs
NCBI-GeneID: 100580571
NCBI-ProteinID: XP_030671639
Ensembl: ENSNLEG00000029261
LinkDB
Position
7b:complement(44771512..44808729)
AA seq 195 aa
MDCEVNNGSGLSDECITNLLVFGFLQSCSDNSFRRELDALGHELPVLAPQWEGYDELQTD
GNRSSHSRLERIEADSESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGLALQLRNTSRSE
EDRNRDLATALEQLLQAYPRDMEKEKTMLVLALLLAKKVASHTPSLLRDVFHTTVNFINQ
NLRTYVRSLARNGMD
NT seq 588 nt   +upstreamnt  +downstreamnt
atggactgtgaggtcaacaatggttccggcctcagtgatgaatgcatcacaaacctactg
gtgtttggcttcctccaaagctgctctgacaacagcttccgcagagagctggacgcgttg
ggccacgagctgccagtgctggctccccagtgggagggctacgatgagctgcagactgac
ggcaaccgcagcagccactcccgcttggaaagaatagaggcagattctgaaagtcaagaa
gacatcatccggaacattgccaggcacctcgcccaggtcggggacagcatggaccgtagc
atccctccaggcctggtgaacggcctggccctgcagctcaggaacaccagccggtcggag
gaggaccggaacagggacctggccactgccctggagcagctgctgcaggcctacccgaga
gacatggagaaggagaagaccatgctggtgctggccctgctgctggccaagaaggtggcc
agtcacacgccgtccttgctccgtgatgtctttcacacaacggtgaattttattaaccag
aacctacgcacctacgtgaggagcttagccagaaacgggatggactga

DBGET integrated database retrieval system